Peer Review History
| Original SubmissionSeptember 24, 2024 |
|---|
|
Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Sarada Prasad Dakua Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse." 4. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 5. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Additional Editor Comments: Please work on the novelty part and address the required comments made by the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The proposed 3D U-Net architecture seems to have some limitations: Firstly, novelty remains a concern; thus, the authors need to present the contributions clearly in the revised manuscript. 1. Due to the high number of parameters, it can easily overfit to the training data, especially if the dataset is small or not diverse enough. 2. The model seems to be computationally intensive, requiring significant memory and processing power, which can be a barrier for some researchers or clinics. Is it possible to use the concept of parallel computation to overcome this? The authors could discuss this by referring the below papers: “Real-time Automated Image Segmentation Technique for Cerebral Aneurysm on Reconfigurable System-On-Chip,” Journal of Computational Science, Elsevier, vol. 27, pp 35-45, 2018. “Lattice-Boltzmann Interactive Blood Flow Simulation Pipeline,” International Journal of Computer Assisted Radiology and Surgery, Springer, vol.15, pp. 629-639, 2020. “Zynq SoC based Acceleration of the Lattice Boltzmann Method,” Concurrency and Computation: Practice and Experience, Wiley, col. 31, issue 17, 2019. "Heterogeneous System-on-Chip based Lattice- Boltzmann Visual Simulation System,” Systems Journal, IEEE, vol. 14, no. 2, pp. 1592-1601, 2020 3. In cases where the glioma regions are much smaller compared to healthy tissue, the model may have difficulty learning the minority class effectively, leading to poor segmentation performance. The performance may be adversely affected by noise and artifacts in the MRI images, which are common in clinical settings. The authors need to discuss if a pre-processing using stocastic resonance theory can be of help. The authors could refer the bew studies while discussing this: "Development of a Cerebral Aneurysm Segmentation Method to Prevent Sentinel Hemorrhage," Network Modeling Analysis in Health Informatics and Bioinformatics, Springer, vol. 12, no. 18, pp. 1-14, 2023. "Toward Computing Cross-Modality Symmetric Non-Rigid Medical Image Registration," IEEE Access, vol. 10, pp. 24528-24539, 2022, "Moving Object Tracking in Clinical Scenarios: Application to Cardiac Surgery and Cerebral Aneurysm Clipping,” International Journal of Computer Assisted Radiology and Surgery, Springer, vol. 14, no. 12, pp. 2165-2176, 2019. “A PCA based Approach for Brain Aneurysm Segmentation,” Journal of Multi Dimensional Systems and Signal Processing, Springer, vol. 29, pp. 257-277, 2018. 4. The authors are encourage to include the potential limitations of the paper. 5. Please discuss the present computational complexity of the model. Reviewer #2: Authors have exaggerated their claims and much of the claims have already been done in literature: 1. "hyperparametric loss function by combining the Dice loss and Focal loss functions" This is a well known combo loss in the literature. 2. Use of pyramid scene parsing and ASPP has been popular for medical image segementation: a. A lightweight neural network with multiscale feature enhancement for liver CT segmentation b. Dense-PSP-UNet: A neural network for fast inference liver ultrasound segmentation 3. Authors claim that registration is part of their method. However, no details of registration have been shared in the the methods section. 4. What's the distinction between MFAB and fusion module? Network figure has to be redesigned and explanation should be made clear. 5. Please dont exaggerate loss as super parameter or hyperparametric. 6. training loss is not interesting why not share validation and test losses for Tables 1 and 2. 7. HD distance as a metrics is skipped in the results section. 8. Lack of comparison with literature. At least 5-7 methods should be implemented and compared with the proposed method. 9. Discussion is missing from the work. 10. Following works should be cited to encourage the use of DL/CNN/UNet for brain tumor segmentation: a. Towards developing a lightweight neural network for liver CT segmentation. b. Neural network-based fast liver ultrasound image segmentation c. Unveiling the future of breast cancer assessment: a critical review on generative adversarial networks in elastography ultrasound d. Advancements in Deep Learning for B-Mode Ultrasound Segmentation: A Comprehensive Review e. Estimating age and gender from electrocardiogram signals: A comprehensive review of the past decade f. Practical utility of liver segmentation methods in clinical surgeries and interventions ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tao Peng Academic Editor PLOS ONE Additional Editor Comments: It is the revised version, while there exists several issues, including lack of comprehensive comparisons of SOTAs, lack of statistical significance, and Insufficient Result Analysis. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Partly Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: No Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: No Reviewer #4: Yes ********** Reviewer #3: This paper resembles a technical report rather than a scientific research article. While the performance results are notable, the following concerns must be addressed before it can be considered for publication. 1.Writing and Grammar: The overall writing of the manuscript requires improvement. For example, phrases like "Validate the dataset" and "Test dataset" on page 14 are unclear. There are grammar errors and clarity issues throughout the manuscript. Tools such as ChatGPT or other AI-based writing assistants can help enhance the writing quality. Ensure that every sentence in the manuscript is reviewed for grammatical accuracy and clarity. 2.State-of-the-Art (SOTA) Comparison: To demonstrate that your method is truly state-of-the-art, it should be compared with the latest models on up-to-date datasets, such as those from the BraTS 2023 challenge. Since most SOTA methods no longer compete on older datasets, references to BraTS 2018 are largely outdated. Additionally, the baseline model used in the paper, U-Net with ASPP, is nearly 9 years old and does not reflect the latest advancements in the field. 3.Emphasis on Novelty: To highlight the novelty of this paper, focus on identifying existing challenges and proposing innovative solutions, rather than combining or stacking existing methods. A clear distinction of how your approach addresses unmet needs in the field will strengthen the paper. 4.Background Information: Commonly known background concepts, such as the original U-Net architecture, ASPP diagrams, multi-scale fusion attention modules, and formulas for Dice/recall/precision, should be abbreviated or summarized concisely to avoid redundancy. 5.Overfitting and Data Inclusion: Changing the loss function alone does not adequately address the overfitting problem. A more effective approach would be to incorporate additional public datasets into the training process. This would improve the model's generalizability and robustness. 6.Test Set Usage (Page 14, Lines 454–455): The statement, "In the test dataset, as the number of training iterations increases, the training loss of each glioma segmentation network model shows a decreasing trend, and the final region stabilizes," raises serious concerns. Did you inadvertently include the test set during training? This practice is entirely unacceptable, as it compromises the validity of your results. If the improvement in Dice score is derived from using the test set during training, this constitutes a form of cheating. The test set must remain completely unseen during training and should only be used for final evaluation. 7.Validation vs. Test Set Results (Table 1): In Table 1, the loss values for the validation set and the test set are shown to be exactly the same. This is highly unusual and warrants a thorough review. Please double-check your experimental setup and ensure there are no errors in your data partitioning or evaluation process. Reviewer #4: Expand Comparative Experiments: Include comparisons with recent high-performing glioma segmentation methods (e.g., those utilizing Transformers or advanced 3D architectures) to comprehensively evaluate the proposed method’s competitiveness. Test the model on additional datasets (e.g., BraTS2020) and consider incorporating multicenter clinical datasets to enhance the study’s real-world applicability. Deepen Ablation Studies: Conduct detailed ablation studies to independently quantify the contributions of the ASPP and MFAB modules, and analyze the effects of varying hyperparameters. Strengthen Result Analysis: Include statistical significance testing and error range reporting to ensure the scientific rigor and reliability of the results. Provide additional visualizations (e.g., segmentation error maps) and analyze the model’s performance in boundary delineation and noise suppression. Improve Methodological Novelty: Consider further optimizing or introducing novel variations to the ASPP and MFAB modules to enhance the originality of the proposed approach. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: Yes: Hengrui Zhao Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tao Peng Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: It is the revised version with better quality, while several minor revisions are needed to handle the residual issues, such as 1) the authors should improve the readability of this submission. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: No Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: No Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: No Reviewer #4: Yes ********** Reviewer #3: I appreciate the authors’ efforts in improving the paper. However, several issues remain unsatisfactory: 1. Grammar and Consistency While the authors revised "Validate the dataset" in one paragraph, it still appears unchanged in Table 1 and Table 3. Please ensure consistency throughout the paper. Standardize expressions such as "training set," "validation set," and "test set" across all instances. "Data set" should be consistently written as "Dataset." I recommend using an AI proofreading tool, such as DeepSeek or Qwen, to check and correct grammar errors throughout the manuscript. 2. Clarity and Terminology The term "Training frequency" appears in Table 1 but lacks explanation. Please clarify its meaning in the table title or description. If it refers to "epoch," consider revising it accordingly. Ensure all terminology in tables and figures is clearly defined within their titles or content. Resolve terminology inconsistencies, such as: "Hollow Space Pyramid Pooling Structure (ASPP)" (page 3) vs. "Atrous Spatial Pyramid Pooling (ASPP)" (page 6). "Evaluating indicator" (Table 5), "Evaluation index" (Section 3.6 title), and "performance metrics" (Section 3.6) should all be standardized as "Evaluation metrics." 3. Conciseness and Redundancy Remove unnecessary background explanations. For instance, Figure 2 (U-Net) should be omitted. Section 3.1 should be condensed into one or two lines. Section 3.6 should be summarized in two lines and merged into Section 4, such as: "We use Dice coefficient, Hausdorff distance (HD95), recall, and precision for evaluation." "HD distance" is incorrect, as it redundantly means "Hausdorff Distance distance." If using HD95 (the standard metric in the field), explicitly specify it. Reviewer #4: Thank you for your careful revisions. After reviewing the revised manuscript, I am pleased to see that all the concerns raised in the previous round have been adequately addressed. The current version is significantly improved and meets the standards for publication. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: Yes: Hengrui Zhao Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
3D-MRI Brain Glioma Intelligent Segmentation Based on Improved 3D U-Net Network PONE-D-24-42605R3 Dear Dr. Wang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tao Peng Academic Editor PLOS ONE Additional Editor Comments (optional): Congratulations! Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-42605R3 PLOS ONE Dear Dr. Wang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tao Peng Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .